Observation of the Immune Response After COVID-19 Additional Vaccine Doses in Chronic Patients in Hemodialysis Therapy
Clinical trial NCT05142501 · TERMINATED
Trial details
- NCT number
- NCT05142501
- Sponsor
- Fresenius Medical Care Deutschland GmbH
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-25
- Primary completion
- 2022-09-02
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.